Cardiovascular systemic lupus erythematosus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

It is now understood that all three layers of the heart (pericardium, myocardium, and endocardium) can be involved by lupus. This chapter reviews not only the cardiac manifestations of active lupus, but also emphasizes on a growing source of morbidity and mortality in systemic lupus erythematosus (SLE) patients, accelerated atherosclerosis. Pericarditis is the most common cardiac manifestation of active lupus, although often it is not evident clinically. Pericarditis in SLE presents in the typical way, with precordial pain, usually positional (aggravated by lying down), often with a pleuritic quality, and sometimes with dyspnea. Other manifestation is pericardial effusion; when present, it is usually small and do not cause hemodynamic problems. Pericardial tamponade has been reported even in treated patients. The major challenge to clinicians is accelerated atherosclerosis, one of the major causes of mortality because it is often difficult to distinguish coronary arteritis from accelerated atherosclerosis. The differentiation of coronary arteritis from atherosclerosis is essential for appropriate management. Coronary artery bypass surgery, angioplasty, or stent placement would be considered in patients with severe atherosclerotic disease, but would be contraindicated in patients with coronary arteritis.

Original languageEnglish (US)
Title of host publicationSystemic Lupus Erythematosus: Fourth Edition
PublisherElsevier Inc.
Pages913-942
Number of pages30
ISBN (Print)9780124339019
DOIs
StatePublished - May 2004

Fingerprint

Systemic Lupus Erythematosus
Arteritis
Atherosclerosis
Pericarditis
Endocardium
Cardiac Tamponade
Pericardial Effusion
Mortality
Pericardium
Angioplasty
Coronary Artery Bypass
Dyspnea
Stents
Coronary Artery Disease
Myocardium
Hemodynamics
Morbidity
Pain

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Cite this

Petri, M. (2004). Cardiovascular systemic lupus erythematosus. In Systemic Lupus Erythematosus: Fourth Edition (pp. 913-942). Elsevier Inc.. https://doi.org/10.1016/B978-012433901-9/50034-X

Cardiovascular systemic lupus erythematosus. / Petri, Michelle.

Systemic Lupus Erythematosus: Fourth Edition. Elsevier Inc., 2004. p. 913-942.

Research output: Chapter in Book/Report/Conference proceedingChapter

Petri, M 2004, Cardiovascular systemic lupus erythematosus. in Systemic Lupus Erythematosus: Fourth Edition. Elsevier Inc., pp. 913-942. https://doi.org/10.1016/B978-012433901-9/50034-X
Petri M. Cardiovascular systemic lupus erythematosus. In Systemic Lupus Erythematosus: Fourth Edition. Elsevier Inc. 2004. p. 913-942 https://doi.org/10.1016/B978-012433901-9/50034-X
Petri, Michelle. / Cardiovascular systemic lupus erythematosus. Systemic Lupus Erythematosus: Fourth Edition. Elsevier Inc., 2004. pp. 913-942
@inbook{a986fe7cc20a4dc7b92015c3e1c1fb69,
title = "Cardiovascular systemic lupus erythematosus",
abstract = "It is now understood that all three layers of the heart (pericardium, myocardium, and endocardium) can be involved by lupus. This chapter reviews not only the cardiac manifestations of active lupus, but also emphasizes on a growing source of morbidity and mortality in systemic lupus erythematosus (SLE) patients, accelerated atherosclerosis. Pericarditis is the most common cardiac manifestation of active lupus, although often it is not evident clinically. Pericarditis in SLE presents in the typical way, with precordial pain, usually positional (aggravated by lying down), often with a pleuritic quality, and sometimes with dyspnea. Other manifestation is pericardial effusion; when present, it is usually small and do not cause hemodynamic problems. Pericardial tamponade has been reported even in treated patients. The major challenge to clinicians is accelerated atherosclerosis, one of the major causes of mortality because it is often difficult to distinguish coronary arteritis from accelerated atherosclerosis. The differentiation of coronary arteritis from atherosclerosis is essential for appropriate management. Coronary artery bypass surgery, angioplasty, or stent placement would be considered in patients with severe atherosclerotic disease, but would be contraindicated in patients with coronary arteritis.",
author = "Michelle Petri",
year = "2004",
month = "5",
doi = "10.1016/B978-012433901-9/50034-X",
language = "English (US)",
isbn = "9780124339019",
pages = "913--942",
booktitle = "Systemic Lupus Erythematosus: Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cardiovascular systemic lupus erythematosus

AU - Petri, Michelle

PY - 2004/5

Y1 - 2004/5

N2 - It is now understood that all three layers of the heart (pericardium, myocardium, and endocardium) can be involved by lupus. This chapter reviews not only the cardiac manifestations of active lupus, but also emphasizes on a growing source of morbidity and mortality in systemic lupus erythematosus (SLE) patients, accelerated atherosclerosis. Pericarditis is the most common cardiac manifestation of active lupus, although often it is not evident clinically. Pericarditis in SLE presents in the typical way, with precordial pain, usually positional (aggravated by lying down), often with a pleuritic quality, and sometimes with dyspnea. Other manifestation is pericardial effusion; when present, it is usually small and do not cause hemodynamic problems. Pericardial tamponade has been reported even in treated patients. The major challenge to clinicians is accelerated atherosclerosis, one of the major causes of mortality because it is often difficult to distinguish coronary arteritis from accelerated atherosclerosis. The differentiation of coronary arteritis from atherosclerosis is essential for appropriate management. Coronary artery bypass surgery, angioplasty, or stent placement would be considered in patients with severe atherosclerotic disease, but would be contraindicated in patients with coronary arteritis.

AB - It is now understood that all three layers of the heart (pericardium, myocardium, and endocardium) can be involved by lupus. This chapter reviews not only the cardiac manifestations of active lupus, but also emphasizes on a growing source of morbidity and mortality in systemic lupus erythematosus (SLE) patients, accelerated atherosclerosis. Pericarditis is the most common cardiac manifestation of active lupus, although often it is not evident clinically. Pericarditis in SLE presents in the typical way, with precordial pain, usually positional (aggravated by lying down), often with a pleuritic quality, and sometimes with dyspnea. Other manifestation is pericardial effusion; when present, it is usually small and do not cause hemodynamic problems. Pericardial tamponade has been reported even in treated patients. The major challenge to clinicians is accelerated atherosclerosis, one of the major causes of mortality because it is often difficult to distinguish coronary arteritis from accelerated atherosclerosis. The differentiation of coronary arteritis from atherosclerosis is essential for appropriate management. Coronary artery bypass surgery, angioplasty, or stent placement would be considered in patients with severe atherosclerotic disease, but would be contraindicated in patients with coronary arteritis.

UR - http://www.scopus.com/inward/record.url?scp=84904029192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904029192&partnerID=8YFLogxK

U2 - 10.1016/B978-012433901-9/50034-X

DO - 10.1016/B978-012433901-9/50034-X

M3 - Chapter

AN - SCOPUS:84904029192

SN - 9780124339019

SP - 913

EP - 942

BT - Systemic Lupus Erythematosus: Fourth Edition

PB - Elsevier Inc.

ER -